KR20110018976A - An extract with red ginseng and herbs - Google Patents
An extract with red ginseng and herbs Download PDFInfo
- Publication number
- KR20110018976A KR20110018976A KR1020090076477A KR20090076477A KR20110018976A KR 20110018976 A KR20110018976 A KR 20110018976A KR 1020090076477 A KR1020090076477 A KR 1020090076477A KR 20090076477 A KR20090076477 A KR 20090076477A KR 20110018976 A KR20110018976 A KR 20110018976A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- red ginseng
- concentrate
- extract
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 51
- 239000000284 extract Substances 0.000 title claims abstract description 22
- 235000008216 herbs Nutrition 0.000 title abstract description 3
- 239000012141 concentrate Substances 0.000 claims abstract description 45
- 235000008504 concentrate Nutrition 0.000 claims abstract description 44
- 241000196324 Embryophyta Species 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 239000000796 flavoring agent Substances 0.000 claims abstract description 11
- 235000019634 flavors Nutrition 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 235000020357 syrup Nutrition 0.000 claims abstract description 8
- 239000006188 syrup Substances 0.000 claims abstract description 8
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- 239000011521 glass Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- 239000000419 plant extract Substances 0.000 claims description 25
- 230000036541 health Effects 0.000 claims description 11
- 241001061264 Astragalus Species 0.000 claims description 10
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 10
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 10
- 235000017803 cinnamon Nutrition 0.000 claims description 10
- 210000004207 dermis Anatomy 0.000 claims description 10
- 235000020710 ginseng extract Nutrition 0.000 claims description 10
- 210000004233 talus Anatomy 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 4
- 240000000171 Crataegus monogyna Species 0.000 claims description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 240000008397 Ganoderma lucidum Species 0.000 claims description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 240000002045 Guettarda speciosa Species 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 abstract description 27
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 26
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 8
- 238000001914 filtration Methods 0.000 abstract description 5
- 241000208340 Araliaceae Species 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 240000001810 Angelica gigas Species 0.000 abstract 1
- 235000018865 Angelica gigas Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 26
- 102000019197 Superoxide Dismutase Human genes 0.000 description 8
- 108010012715 Superoxide dismutase Proteins 0.000 description 8
- 244000061520 Angelica archangelica Species 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 241001247821 Ziziphus Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003178 anti-diabetic effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 241001092040 Crataegus Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
- A23L2/46—Preservation of non-alcoholic beverages by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 홍삼농축액, 당귀, 오가피, 황기, 천궁, 백출, 계피, 진피, 갈근, 건강, 대추, 맥아, 숙지황, 시인, 산사, 홍삼정 등의 추출 및 농축액을 유효성분으로 함유하는 홍삼정 제조에 관한 것이다.The present invention relates to a hongsamjeong prepared containing extracts and concentrates, such as Red Ginseng extract, Angelica, Acanthopanax, Astragalus, Cnidium, baekchul, cinnamon, dermis, Puerariae Radix, health, jujube, malt, sukjihwang, poet, Crataegus, hongsamjeong as an active ingredient will be.
생활수준의 향상과 빠른 생활의 식생활 패턴으로 식이에 대한 중요성이 강조되고 있고, 정신 활동의 비중이 높아짐에 따른 운동부족과 스트레스의 축적으로 인한 비만과 같은 성인병이 사회문제로 대두되면서 저칼로리식품 및 기능성 건강식품에 대한 관심이 높아지고 있다. 건강에 대한 관심이 높아지면서 무공해 작물에 대한 소비가 늘어났고, 약용식물 대한 중요성이 높이 평가되어 그 수요가 급증하므로 고품질 약용식물의 안정적 공급이 절대적으로 필요하다. 한방에서 쓰이는 약용 자원의 개발, 유효 성분의 동정 및 우수 신품종의 육성이 절실하다.The importance of diet is emphasized by improving living standards and eating patterns of fast living, and low-calorie foods and functionalities as adult diseases such as obesity caused by lack of exercise and stress accumulation due to increasing weight of mental activity are emerging as social problems. There is a growing interest in health food. As interest in health has increased, consumption of non-polluting crops has increased, and the importance of medicinal plants is highly appreciated and the demand is soaring, so stable supply of high quality medicinal plants is absolutely necessary. The development of medicinal resources for oriental medicine, the identification of active ingredients and the upbringing of new varieties are urgently needed.
약용식물학은 약용식물에 대한 일반적인 지식과 이의 분류를 위한 방법 및 성분효용 등에 대한 개괄적인 내용을 연구하는 학문으로서 실용응용학문에 속한다. 약용으로 사용되었던 생물 중 대부분을 차지하고 있는 것이 식물이었기 때문에 한의학에서 기초단위로 연구되어져야 할 학문인 것이다. 과거에서 현재까지 지속되어오고 있는 질병치료의 방법 중 약물치료의 중요한 부분을 차지하고 있는 약용식물은 최근에 들어 현대 의약품의 발견에 주요한 재원으로 활용되어 지고 있는 것을 볼 수 있다. Medicinal botanical science is a study of general knowledge on medicinal plants, a method for classifying them, and an overview of their usefulness. Since most of the organisms used for medicinal plants were plants, it is a study that should be studied as a basic unit in oriental medicine. Medicinal plants, which are an important part of drug treatment, have been used as a major resource for the discovery of modern medicines.
인삼 (Panax ginseng C.A. Meyer)은 오가피나무과 (Araliaceae) 인삼속 (Panax)에 속하는 다년생 초본류로서 한방에서는 그 뿌리를 약용으로 사용하고 있으며(Ha et al ., 2005), 한국을 비롯한 중국 등 동아시아 지역에서는 적어도 2천년 이상의 오랜 약용 역사를 가지고 있으며, 생약 중 가장 고귀한 약재로 이용되어 왔다. 전통적인 약물로서 인삼은 많은 과학적 연구 결과에 의해 다양한 효능이 입증되어 감에 따라 건강 증진을 위한 인삼의 가치는 동양뿐만 아니라 서양에서도 인정되어 지금은 세계 각국에서 의료용 또는 건강식품으로 널리 활용되고 있다. Ginseng ( Panax ginseng CA Meyer) is using a herbaceous perennial belonging to Araliaceae Acanthopanax (Araliaceae) ginseng (Panax) as medicated its roots in one shot (Ha et al . , 2005), has a long medicinal history of at least 2,000 years in East Asia, including Korea and China, and has been used as the most medicinal herb among herbal medicines. As traditional medicine, ginseng has been proved various effects by many scientific research results, the value of ginseng for health promotion is recognized in the West as well as in the East, and is now widely used as a medical or health food in various countries around the world.
인삼의 종류로는 수삼, 백삼, 홍삼, 태극삼 등으로 분류되는데, 수삼은 재배한 인삼으로 70~80%의 수분을 함유하고 있으며, 가공하지 않은 상태의 인삼으로서 일명 생삼이라 하고, 백삼은 수삼을 원료로 껍질을 벗기거나 그대로 햇볕, 열풍 또는 기타의 방법으로 건조한 것으로 말린 형태에 따라 직삼, 반곡삼, 곡삼으로 구분하고 있으며, 홍삼은 수삼을 껍질을 벗기지 않은 상태로 세삼 후 증숙, 건조, 가공공정 등을 거쳐 수분함량이 14% 이하가 되도록 가공한 것을 말하며, 수삼을 찌고 말리는 과정에서 화학작용이 발생되어 특정 사포닌과 유효성분의 함량이 일반 인삼에 비해 증가한다.The types of ginseng are classified into ginseng, white ginseng, red ginseng, and taeguk ginseng. Ginseng is a cultivated ginseng that contains 70 to 80% of moisture, and is called raw ginseng. Peeled as raw material or dried as it is by sunlight, hot air, or other methods, depending on the dried form, it is divided into direct ginseng, semi-ginseng, and grain ginseng, and red ginseng is steamed, dried, and processed after three ginsengs without peeling ginseng. It refers to the processed water so that the water content is less than 14% through, etc., the chemical action occurs in the process of steaming and drying the ginseng, the content of the specific saponin and the active ingredient increases compared to the general ginseng.
인삼의 주요 생리활성 물질로는 ginsenosides, polyacetylenes, 산성다당체, 페놀성 물질 등이 알려져 있으며, 주요 효능으로는 중추신경계에 대한 작용 (Tagaki, 1972), 뇌기능 항진 효능 (Zhang et al ., 1990), 항발암작용과 항암활성 (Kumar, 1993), 면역기능 조절 작용 (Brekhman, 1969), 항당뇨작용 (Kimura et al., 1985), 간기능 항진효능(Yamamoto et al., 1988), 혈압조절작용 (Takagi et al ., 1974), 항산화 활성 및 노화억제 효능 (Fushitani et al ., 1995) 등이 보고되었다. The major bioactive substances of ginseng are ginsenosides, polyacetylenes, acidic polysaccharides, such as phenolic compounds are known and, acting on the central nervous system is the primary efficacy (Tagaki, 1972), brain hyperactivity potency (Zhang et al . , 1990), anticarcinogenic and anticancer activity (Kumar, 1993), immunomodulatory activity (Brekhman, 1969), antidiabetic activity (Kimura et al. , 1985), anti-diabetic effect (Yamamoto et. al ., 1988), blood pressure regulating action (Takagi et. al . , 1974), antioxidant activity and anti-aging effect (Fushitani et al . , 1995).
Rb1: 배아발달에 관여, 골수세포의 DNA(RNA-지질합성, 촉진작용), 성호르몬 생성 촉진을 통한 번식시스템에 영향을 줌Rb1: Involved in embryonic development, affects the reproductive system through bone marrow cell DNA (RNA-lipid synthesis, facilitation) and promotes sex hormone production
Rc: 진통작용, 단백질 및 지질합성 촉진Rc: promotes analgesic, protein and lipid synthesis
Rb2: 항당뇨 작용, 면역조절작용, 콜레스테롤 대사 Rb2: antidiabetic, immunomodulatory, cholesterol metabolism
Rb3: 생리활성 Rb3: bioactive
Rd: 부신피질 호르몬 분비 촉진 작용Rd: corticosteroid secretion promoting effect
Rg3: 암세포전이 억제작용, 혈소판응집억제, 항암제 내성 억제작용 Rg3: inhibits cancer cell metastasis, inhibits platelet aggregation, inhibits anticancer drug resistance
Rh2: 암세포 증식 억제, 종양증식 억제, 피부 면역 효과Rh2: inhibit cancer cell proliferation, suppress tumor growth, cutaneous immune effect
이러한 인삼의 효능을 이용한 다양한 형태의 음료나 차가 개발되어 이용되고 있으나, 식물성 소재로부터 다른 효능을 보충하거나 상승효과를 가져올 수 있는 복합형태의 인삼 및 식물 추출물과 농축액을 이용한 기능성 식품의 형태는 없는 실정이다.Various types of beverages and teas have been developed and used using the effects of ginseng, but there are no functional foods using complex ginseng and plant extracts and concentrates that can supplement other effects from plant materials or bring synergistic effects. to be.
본 발명은 상기한 종래 문제점을 해결하기 위한 것으로, 식생활의 불균형과 음주, 흡연 및 스트레스에 의한 성인병의 발생과 노인인구의 건강 유지를 위한 대체 건강 식이를 제공하기 위한 것으로, 피로회복, 면역증강, 혈행개선 및 성인병 예방 및 노화방지를 위한 새로운 형태의 건강지향 보조식품을 제공할 수 있다. The present invention is to solve the above-mentioned conventional problems, to provide an alternative health diet for maintaining the health of the elderly population and the occurrence of geriatric disease caused by the imbalance of diet and drinking, smoking and stress, fatigue recovery, immune augmentation, New forms of health-oriented supplements can be provided to improve blood circulation, prevent adult disease, and prevent aging.
상기 목적을 달성하기 위하여, 본 발명은 인삼을 추출기에서 인삼의 5배에 해당되는 50% 주정(물:주정=1:1)으로 85℃에서 24시간 씩 3회를 반복하여 인삼추출액을 제조한 후, 여과하여 농축기로 이송하여 감압 650-700mmHg, 온도 57-63℃ 조건에서 농축하여 홍삼농축액을 제조하는 제1단계,In order to achieve the above object, the present invention prepared a ginseng extract by repeating three times at 85 ℃ with 50% alcohol (water: alcohol = 1: 1) corresponding to 5 times the ginseng extractor in ginseng extract After the first step of filtering and transferring to a concentrator under reduced pressure 650-700mmHg, temperature 57-63 ℃ conditions to produce a red ginseng concentrate,
당귀 10중량부, 오가피 10중량부, 황기 7중량부, 천궁 7중량부, 백출 7중량부, 계피 7중량부, 진피 7중량부, 갈근 7중량부, 건강 7중량부, 대추 7중량부, 맥아 7중량부, 숙지황 6중량부, 시인 6중량부, 산사 5중량부를 추출기에 넣고 5배의 물로 추출온도 85℃에서 24시간 추출한 후, 농축기를 이용하여 감압 650-700mmHg, 온도 57-63℃에서 농축하여 고형분 60%의 식물추출농축액을 제조하는 제2단계,Angelica 10 parts by weight, Ogapi 10 parts by weight, Astragalus 7 parts by weight, Cheongung 7 parts by weight, Baekchul 7 parts by weight, Cinnamon 7 parts by weight, Dermis 7 parts by weight, Brown root 7 parts by weight, Health 7 parts by weight, Jujube 7 parts by weight, 7 parts by weight of malt, 6 parts by weight of sucrose and 6 parts by weight of poet, 5 parts by weight of hawthorn were added to the extractor and extracted with 5 times of water at extraction temperature of 85 ° C for 24 hours, using a condenser to reduce the pressure to 650-700mmHg, temperature of 57-63 ° C. A second step of preparing a plant extract concentrate having a solid content of 60% by concentration in
배합기에서 상기 제1단계의 홍삼농축액 10중량%, 상기 제2단계의 식물추출농축액 55중량%, 물엿 34.7%, 허브향 0.3중량%로 혼합하는 제3단계,A third step of mixing in a blender 10% by weight of red ginseng concentrate of the first step, 55% by weight of the plant extract concentrate of the second step, starch syrup 34.7%, herb flavor 0.3% by weight,
상기 제3단계의 혼합물을 85℃에서 30분간 가열 살균하고 유리병에 포장하는 단계로 이루어지는 것을 특징으로 하는 홍삼 및 식물추출물이 함유된 홍삼정의 제조방법에 관한 것이다.It relates to a method for producing red ginseng and plant extract containing red ginseng, characterized in that the step of heat-sterilizing the mixture of the third step for 30 minutes at 85 ℃ and packaging in a glass bottle.
본 발명은 또한 식물추출농축액을 제조하는 제2단계의 식물성분이 당귀 5중량부, 오가피 5중량부, 대추 3중량부, 천궁 3중량부, 숙지황 3중량부, 황기 3중량부, 작약 3중량부, 영지 3중량부, 갈근 3중량부, 백출 3중량부, 곽향 2.5중량부, 산약 2중량부, 감초 2중량부, 맥아 2중량부, 백봉령 2중량부, 진피 2중량부, 계피 1중량부, 인진 1중량부로 이루어지는 것을 특징으로 하는 홍삼 및 식물추출물이 함유된 홍삼정의 제조방법을 포함한다. The present invention is also the plant component of the second step to prepare a plant extract concentrate 5 parts by weight of Angelica, 5 parts by weight of Ogapi, 3 parts by weight jujube, 3 parts by weight of cheongung, 3 parts by weight of succulent sulfur, 3 parts by weight of Astragalus, 3 parts by weight peony , 3 parts by weight of ganoderma lucidum, 3 parts by weight, white extract 3 parts by weight, 2.5 parts by weight, acid powder 2 parts by weight, licorice 2 parts by weight, malt 2 parts by weight, Baekbongryeong 2 parts by weight, dermis 2 parts by weight, cinnamon 1 part , Red ginseng and plant extract containing red ginseng tablets characterized in that consisting of 1 part by weight of jinjin.
본 발명은 상기의 방법으로 제조된 홍삼정을 포함한다.The present invention includes red ginseng tablets prepared by the above method.
본 발명에 의한 홍삼농축액과 식물추출농축액이 함유된 홍삼정은 건강에 이로운 식물성 소재를 최적화 선택하여 최적의 배합비와 공정으로 제조되어 홍삼 및 각각 식물의 고유한 유용 성분이 추출 및 농축과정에서 효율적으로 용출되어 홍삼을 비롯한 선택된 약재의 효능과 기능을 그대로 흡수할 수 있으며, 식물의 이롭지 못한 고유의 향과 맛이 조화롭게 어우러지도록 배합되어 장기간 복용함에 부담이 없어 지속복용이 가능하도록 한 피로회복, 항산화, 면역력 증강, 혈소판 응집 억제 를 통한 혈액흐름에 도움 등의 기능성 성분이 성인병과 노화를 억제하여 새로운 형태의 기능성 건강보조식품을 기대할 수 있다.Red ginseng extract and red ginseng extract containing plant extract concentrate according to the present invention are optimized and selected for the beneficial vegetable material and are manufactured in an optimal blending ratio and process, so that red ginseng and the unique useful components of each plant are efficiently eluted during the extraction and concentration process. It can absorb the efficacy and function of selected medicinal herbs including red ginseng as it is, and it is formulated to harmoniously combine the unfavorable aromas and tastes of plants. Functional ingredients such as enhanced blood flow through suppression of platelet aggregation can inhibit adult diseases and aging, and new types of functional health supplements can be expected.
이하, 본 발명의 기능성 건강보조 식품의 제조방법을 상세히 설명하면 다음과 같다.Hereinafter, the manufacturing method of the functional health supplement food of the present invention in detail.
인삼을 추출기에서 인삼의 5배에 해당되는 50% 주정(물:주정=1:1)으로 85℃에서 24시간 씩 3회를 반복하여 인삼추출액을 제조한 후, 여과하여 농축기로 이송하여 감압 650-700mmHg, 온도 57-63℃ 조건에서 농축하여 홍삼농축액을 제조하는 제1단계,Ginseng extract from the extractor to 50% alcohol (water: alcohol = 1: 1) three times at 85 ℃ three times for 24 hours to prepare a ginseng extract, filtered and transferred to a concentrator under reduced pressure 650 A first step of preparing red ginseng concentrate by concentrating at -700mmHg and a temperature of 57-63 ° C;
당귀 10중량부, 오가피 10중량부, 황기 7중량부, 천궁 7중량부, 백출 7중량부, 계피 7중량부, 진피 7중량부, 갈근 7중량부, 건강 7중량부, 대추 7중량부, 맥아 7중량부, 숙지황 6중량부, 시인 6중량부, 산사 5중량부를 추출기에 넣고 5배의 물로 추출온도 85℃에서 24시간 추출한 후, 농축기를 이용하여 감압 650-700mmHg, 온도 57-63℃에서 농축하여 고형분 60%의 식물추출농축액을 제조하는 제2단계,Angelica 10 parts by weight, Ogapi 10 parts by weight, Astragalus 7 parts by weight, Cheongung 7 parts by weight, Baekchul 7 parts by weight, Cinnamon 7 parts by weight, Dermis 7 parts by weight, Brown root 7 parts by weight, Health 7 parts by weight, Jujube 7 parts by weight, 7 parts by weight of malt, 6 parts by weight of sucrose and 6 parts by weight of poet, 5 parts by weight of hawthorn were added to the extractor and extracted with 5 times of water at extraction temperature of 85 ° C for 24 hours, using a condenser to reduce the pressure to 650-700mmHg, temperature of 57-63 ° C. A second step of preparing a plant extract concentrate having a solid content of 60% by concentration in
배합기에서 상기 제1단계의 홍삼농축액 10중량%, 상기 제2단계의 식물추출농축액 55중량%, 물엿 34.7%, 허브향 0.3중량%로 혼합하는 제3단계,A third step of mixing in a blender 10% by weight of red ginseng concentrate of the first step, 55% by weight of the plant extract concentrate of the second step, starch syrup 34.7%, herb flavor 0.3% by weight,
상기 제3단계의 혼합물을 85℃에서 30분간 가열 살균하고 유리병에 포장하는 단계로 이루어지는 것을 특징으로 하는 홍삼 및 식물추출물이 함유된 홍삼정의 제조방법으로 이루어진다.The mixture of the third step is heat sterilized for 30 minutes at 85 ° C and made of red ginseng extract containing plant extracts characterized in that it comprises a step of packaging in a glass bottle.
본 발명은 또한 식물추출농축액을 제조하는 제2단계의 식물성분이 당귀 5중량부, 오가피 5중량부, 대추 3중량부, 천궁 3중량부, 숙지황 3중량부, 황기 3중량부, 작약 3중량부, 영지 3중량부, 갈근 3중량부, 백출 3중량부, 곽향 2.5중량부, 산약 2중량부, 감초 2중량부, 맥아 2중량부, 백봉령 2중량부, 진피 2중량부, 계피 1중량부, 인진 1중량부로 이루어지는 것을 특징으로 하는 홍삼 및 식물추출물이 함유된 홍삼정의 제조방법을 포함한다. The present invention is also the plant component of the second step to prepare a plant extract concentrate 5 parts by weight of Angelica, 5 parts by weight of Ogapi, 3 parts by weight jujube, 3 parts by weight of cheongung, 3 parts by weight of succulent sulfur, 3 parts by weight of Astragalus, 3 parts by weight peony , 3 parts by weight of ganoderma lucidum, 3 parts by weight, white extract 3 parts by weight, 2.5 parts by weight, acid powder 2 parts by weight, licorice 2 parts by weight, malt 2 parts by weight, Baekbongryeong 2 parts by weight, dermis 2 parts by weight, cinnamon 1 part , Red ginseng and plant extract containing red ginseng tablets characterized in that consisting of 1 part by weight of jinjin.
(1) 홍삼농축액제조(1) Red ginseng concentrate production
① 원료구입 및 선별 : 인삼산업법에 적합한 인삼근으로 만들어진 홍삼을 사용한다.① Purchasing and screening raw materials: Use red ginseng made with ginseng roots suitable for the Ginseng Industry Act.
② 추출 : 원료삼을 추출기에 넣고 원료량의 5배상당의 물과 주정을 혼합한 용매(50%이상)로 추출온도 85℃에서 24시간 동안 추출한다. 바람직하게는 이를 3회 반복한다.② Extraction: Put the raw ginseng into the extractor and extract it for 24 hours at the extraction temperature of 85 ℃ with a solvent (50% or more) mixed with 5 times the amount of water and alcohol. Preferably this is repeated three times.
③ 저장 : 추출한 액을 여과과정을 거쳐 저장탱크에 저장한다.③ Storage: The extracted liquid is stored in the storage tank through filtration process.
④ 이송 : 여과한 액을 농축기로 이송한다.④ Transfer: Transfer the filtered liquid to the concentrator.
⑤ 농축 : 이송된 액을 농축기를 이용 감압 650-700mmHg, 온도 57-63℃에서 농축한다.⑤ Concentration: Concentrate the transferred liquid at a reduced pressure of 650-700mmHg and a temperature of 57-63 ℃ using a concentrator.
⑥ 검사 : 농축액을 홍삼제품규격에 따라 적합한지 여부를 검사한다.⑥ Inspection: It checks whether the concentrate is suitable according to red ginseng product standard.
(2) 식품추출농축액 제조(2) Manufacture of food extract concentrate
① 칭량 : 각종 원료(당귀, 오가피, 황기, 천궁, 백출, 계피, 진피, 갈근, 건강, 대추, 맥아, 숙지황, 시인, 산사)를 배합비에 따라 칭량한다.① Weighing: Weigh various raw materials (Dangui, Ogapi, Astragalus, Cheongung, Baekchul, Cinnamon, Dermis, Root, Health, Jujube, Malt, Sukji Hwang, Poet, Sansa) according to the mixing ratio.
② 추출 : 각종 원료를 추출기에 넣고 원료량의 5배상당의 물로 추출온도 85℃에서 24시간 동안 추출한다.② Extraction: Put various raw materials into the extractor and extract with water equivalent to 5 times the amount of raw materials at extraction temperature of 85 ℃ for 24 hours.
③ 이송 : 추출한 액을 여과과정을 거쳐 농축기로 이송한다.③ Transfer: Transfer the extracted liquid to the concentrator through filtration process.
④ 농축 : 이송된 액을 농축기를 이용 감압 650-700mmHg, 온도 57-63℃에서 농축한다.④ Concentration: Concentrate the transferred liquid at 650-700mmHg and 57-63 ℃ under reduced pressure using a concentrator.
(3) 이송 : 식물추출농축액을 여과과정을 거쳐 배합기로 이송한다.(3) Transfer: Transfer the plant extract concentrate to the blender through filtration process.
(4) 배합 : 배합기에서 식물추출농축액과 홍삼농축액, 물엿, 허브향을 배합비에 따라 넣고 배합한다.(4) Mixing: Mix the plant extract concentrate, red ginseng concentrate, syrup and herb flavor in the blender according to the blending ratio.
(5) 살균 : 배합액을 85℃에서 30분간 살균한다.(5) Sterilization: Sterilize the mixture at 85 ° C for 30 minutes.
(6) 포장 : 유리병에 100ml 또는 250ml씩 소포장한 후 자사포장규격에 따라 겉포장을 한다.(6) Packing: 100ml or 250ml are packed in glass bottles and then packed in accordance with the company's packaging standards.
(7) 출하 : 품질검사결과 적합한 경우 출하한다.(7) Shipment: Ship to the quality inspection result if appropriate.
(3) 식품추출농축액 제조(3) Manufacture of food extract concentrate
(1) 성상 : 암갈색의 액상제품(1) Appearance: Dark brown liquid product
(2) 진세노사이드 Rg1과 Rb1의 합: 표시량(1.0mg/g)의 80~150%(2) Sum of ginsenosides Rg1 and Rb1: 80-150% of the indicated amount (1.0 mg / g)
(3) 세균수: 1g 당 100이하(3) Number of bacteria: 100 or less per 1g
(4) 대장균수: 음성이어야 한다.(4) Coliform bacillus: should be negative.
< 실험예 1>Experimental Example 1
인삼을 추출기에서 인삼의 5배에 해당되는 50% 주정(물:주정=1:1)으로 85℃에서 24시간 씩 3회를 반복하여 인삼추출액을 제조한 후, 여과하여 농축기로 이송하여 감압 650-700mmHg, 온도 57-63℃ 조건에서 농축하여 홍삼농축액을 제조하였다.Ginseng extract from the extractor to 50% alcohol (water: alcohol = 1: 1) three times at 85 ℃ three times for 24 hours to prepare a ginseng extract, filtered and transferred to a concentrator under reduced pressure 650 Red ginseng concentrate was prepared by concentrating at -700mmHg and a temperature of 57-63 ° C.
< 실험예 2>Experimental Example 2
당귀 10중량부, 오가피 10중량부, 황기 7중량부, 천궁 7중량부, 백출 7중량부, 계피 7중량부, 진피 7중량부, 갈근 7중량부, 건강 7중량부, 대추 7중량부, 맥아 7중량부, 숙지황 6중량부, 시인 6중량부, 산사 5중량부를 추출기에 넣고 5배의 물로 추출온도 85℃에서 24시간 추출한 후, 농축기를 이용하여 감압 650-700mmHg, 온도 57-63℃에서 농축하여 고형분 60%의 식물추출농축액을 제조하였다.Angelica 10 parts by weight, Ogapi 10 parts by weight, Astragalus 7 parts by weight, Cheongung 7 parts by weight, Baekchul 7 parts by weight, Cinnamon 7 parts by weight, Dermis 7 parts by weight, Brown root 7 parts by weight, Health 7 parts by weight, Jujube 7 parts by weight, 7 parts by weight of malt, 6 parts by weight of sucrose and 6 parts by weight of poet, 5 parts by weight of hawthorn were added to the extractor and extracted with 5 times of water at extraction temperature of 85 ° C for 24 hours, using a condenser to reduce the pressure to 650-700mmHg, temperature of 57-63 ° C. Concentrated at to prepare a plant extract concentrate of 60% solids.
< 실험예 3>Experimental Example 3
상기 실험예1의 홍삼농축액 10중량부와 상기 제2단계의 식물추출농축액 55중량부를 혼합하여 준비하였다.10 parts by weight of the red ginseng concentrate of Experimental Example 1 and 55 parts by weight of the plant extract concentrate of the second step were prepared.
SODSOD 유사활성Pseudo-activity
활성산소를 제거하는 효소인 SOD(superoxide dismutase)는 몸 안에 필요 이상의 활성산소가 생겼을 때 이것을 제거하는 작용을 함으로써, 활성산소의 산화반응으로 말미암아 발생하는 질병을 예방하거나 치료하는 역할을 한다. SOD 유사활성 측정방법은 Marklund의 방법(1974)에 따라 각 시료 추출액 80㎕에 Tris-HCl 1,200㎕와 7.2 mM Pyrogallol 80㎕를 가하여 잘 혼합하여 25℃ 항온수조에서 10분간 반응시킨 다음, 1N HCl 40㎕를 가하여 반응을 정지시키고 420㎚에서 흡광도를 측정하여 계산하였다. SOD는 superoxide radical을 산소로 산화시키는 천연 항산화제이다. 일부 저분자 물질들은 산화방지 및 노화억제 등 SOD와 유사한 활성을 지니면서 열에 약하고 흡수율이 낮은 SOD의 단점을 보완하는 기능을 갖는다. 이들은 SOD와 결합된 phenol계 화합물로 밝혀진 바 있으며, 우리나라에서는 감잎차, 과채류 등의 SOD 유사활성에 대해 조사되었다.SOD (superoxide dismutase), an enzyme that removes free radicals, acts to remove excess free radicals from the body when necessary, thereby preventing or treating diseases caused by oxidation of free radicals. SOD-like activity was measured by adding 1,200 μl of Tris-HCl and 80 μl of 7.2 mM Pyrogallol to 80 μl of each sample extract according to Marklund's method (1974), and reacting for 10 minutes in a 25 ° C. constant temperature water bath. 반응 was added to stop the reaction and calculated by measuring absorbance at 420 nm. SOD is a natural antioxidant that oxidizes superoxide radicals into oxygen. Some low-molecular materials have a similar function to SOD, such as anti-oxidation and anti-aging, and have the function of compensating for the disadvantages of SOD, which is weak to heat and has low absorption rate. These have been found to be phenol-based compounds combined with SOD, and SOD-like activity of persimmon leaf tea, fruit and vegetable was investigated in Korea.
Table 1. SOD 유사활성Table 1. SOD-like activity
전자공여능Electron donating ability 함량 content
EDA (electron donating ability)의 측정은 Blios(1958)의 방법에 따라 시료 100㎕를 가하고 1x10-⁴M DPPH 1,400㎕를 잘 혼합하여 4분경과 후에 원심분리기에서 12,000rpm으로 3분 동안 원심분리 하였다. 상등액을 취하고 10분경과 후 525 nm에서 흡광도를 측정한 것을 무첨가구와 비교하여 백분율로 나타내었다. DPPH는 아스코르빈산 및 토코페롤, polyhydroxy 방향족화합물, 방향족 아민류에 의해 전자나 수소를 받아 불가역적으로 안정한 분자를 형성하여 환원되어짐에 따라 짙은 자색이 탈색되어지는 원리를 이용하여 측정하였다.EDA (electron donating ability) was measured according to the method of Blios (1958), 100 μl of the sample was added and 1,400 μl of 1 × 10-⁴M DPPH were mixed well, followed by centrifugation at 12,000 rpm for 3 minutes in a centrifuge. After taking the supernatant, the absorbance measured at 525 nm after 10 minutes was expressed as a percentage compared to the no addition. DPPH was measured using the principle that dark purple decolorizes as it is reduced by receiving electrons or hydrogen by ascorbic acid, tocopherol, polyhydroxy aromatic compounds, and aromatic amines to form irreversibly stable molecules.
Table 2. EDA (전자공여능)Table 2. EDA
본 발명의 특징 및 이점들은 첨부도면에 의거한 다음의 상세한 설명으로 더욱 명백해질 것이다. 이에 앞서, 본 명세서 및 청구범위에 사용된 용어나 단어는 발명자가 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.The features and advantages of the present invention will become more apparent from the following detailed description based on the accompanying drawings. Prior to this, the terms or words used in the present specification and claims are defined in the technical spirit of the present invention on the basis of the principle that the inventor can appropriately define the concept of the term in order to explain his invention in the best way. It must be interpreted to mean meanings and concepts.
<실시예 1>≪ Example 1 >
인삼을 추출기에서 인삼의 5배에 해당되는 50% 주정(물:주정=1:1)으로 85℃에서 24시간 씩 3회를 반복하여 인삼추출액을 제조한 후, 여과하여 농축기로 이송 하여 감압 650-700mmHg, 온도 57-63℃ 조건에서 농축하여 홍삼농축액을 제조하였다. 당귀 10g, 오가피 10g, 황기 7g, 천궁 7g, 백출 7g, 계피 7g, 진피 7g, 갈근 7g, 건강 7g, 대추 7g, 맥아 7g, 숙지황 6g, 시인 6g, 산사 5g를 추출기에 넣고 5배의 물로 추출온도 85℃에서 24시간 추출한 후, 농축기를 이용하여 감압 650-700mmHg, 온도 57-63℃에서 농축하여 고형분 60%의 식물추출농축액을 제조하였다. 배합기에서 상기 제1단계의 홍삼농축액 10중량%, 상기 제2단계의 식물추출농축액 55중량%, 물엿 34.7%, 허브향 0.3중량%로 혼합한 후, 85℃에서 30분간 가열 살균하고 유리병에 포장하였다. Ginseng extract was prepared by extracting ginseng extract three times for 24 hours at 85 ° C. with 50% alcohol (water: alcohol = 1: 1) corresponding to 5 times of ginseng in the extractor. Red ginseng concentrate was prepared by concentrating at -700mmHg and a temperature of 57-63 ° C. Angelica 10g, Ogapi 10g, Astragalus 7g, Cheongung 7g, Baekchul 7g, Cinnamon 7g, Dermis 7g, Brown root 7g, Health 7g, Jujube 7g, Malt 7g, Sulfur yellow 6g, Poet 6g, Sansa 5g and extract with 5 times water After extracting at a temperature of 85 ℃ for 24 hours, using a condenser to concentrate under reduced pressure 650-700mmHg, temperature 57-63 ℃ to prepare a plant extract concentrate of 60% solids. 10% by weight of the red ginseng concentrate of the first step, 55% by weight of the plant extract concentrate of the second step, 34.7% starch syrup, 0.3% by weight of the herb flavor, and then heat sterilized at 85 ℃ for 30 minutes Packed.
<실시예 2><Example 2>
상기 실시예 1에서 물엿과 허브향을 첨가하지 않고서 동일한 방법으로 제조하였다.In Example 1 was prepared in the same manner without adding syrup and herbal flavors.
<실시예 3><Example 3>
상기 실시예 1에서 식물추출농축액을 첨가하지 않고, 상기 제1단계의 홍삼농축액 10중량%, 물 55중량%, 물엿 34.7%, 허브향 0.3중량%로 혼합한 후, 85℃에서 30분간 가열 살균하고 유리병에 포장하였다. After adding the plant extract concentrate in Example 1, 10% by weight of red ginseng concentrate, 55% by weight of water, 34.7% by starch syrup, 0.3% by weight of herb flavor, heat sterilization for 30 minutes at 85 ℃ And packed in glass bottles.
상기 실시예를 통해서 제조된 샘플과 고형분 45%의 일반적인 홍삼 농축액에 대하여, 훈련된 관능검사 요원 10명을 대상으로 3회의 반복에 의한 관능 평가를 실 시하였다. 관능검사 항목은 향, 맛, 색, 전체적인 기호도에 대하여 실시하였으며 5점 척도법에 따라 5점을 만점으로 하여 다음의 평가기준에 의하여 피시험자가 점수를 기록한 후 이들의 평균값을 구하여 기록하였다. For the sample prepared by the above example and the general red ginseng concentrate of 45% solid content, the sensory evaluation was performed by three repetitions of 10 trained sensory test personnel. The sensory test items were conducted on fragrance, taste, color, and overall acceptability. Five points were scored according to the five-point scale method, and the test subjects recorded scores according to the following evaluation criteria.
5: 아주 좋다 ~ 1: 아주 나쁘다 5: very good ~ 1: very bad
기호도Overall
Likelihood
본 발명의 실시예 1에 의하여 제조된 홍삼정이 비교예보다 맛과 풍미에서 우월한 관능적 점수를 보였으며, 색에서도 큰 차이를 보이지 않았다. 묘사 분석에서도, 본 발명의 실시예 1이 홍삼 고유의 색택과 향미가 있으면서도 홍삼과 식물성분의 맛과 향이 조화롭게 어우러져 먹기에 부담이 없다고 응답하였다.The red ginseng tablet prepared by Example 1 of the present invention showed a superior sensory score in taste and flavor than the comparative example, and did not show any significant difference in color. Also in the description analysis, Example 1 of the present invention responded that there was no burden to eat because the taste and aroma of the red ginseng and the plant components harmonized harmoniously while the red ginseng had its own color and flavor.
도 1은 본 발명의 홍삼 및 식물추출물이 함유된 홍삼정의 제조과정을 도시한 공정도이다.1 is a process chart showing the manufacturing process of red ginseng tablets containing red ginseng and plant extract of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090076477A KR101144920B1 (en) | 2009-08-19 | 2009-08-19 | An Extract with Red Ginseng and Herbs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090076477A KR101144920B1 (en) | 2009-08-19 | 2009-08-19 | An Extract with Red Ginseng and Herbs |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110018976A true KR20110018976A (en) | 2011-02-25 |
KR101144920B1 KR101144920B1 (en) | 2012-05-11 |
Family
ID=43776418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090076477A KR101144920B1 (en) | 2009-08-19 | 2009-08-19 | An Extract with Red Ginseng and Herbs |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101144920B1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103494894A (en) * | 2013-10-09 | 2014-01-08 | 南京中医药大学 | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof |
CN104082745A (en) * | 2014-07-10 | 2014-10-08 | 山西大学 | Medicated food for conditioning blood-stasis constitution and improving immune adjustment capability and preparation method of medicated food |
CN104382166A (en) * | 2014-11-11 | 2015-03-04 | 防城港市万景林业有限公司 | Kudzuvine root milk beverage formula |
CN104382168A (en) * | 2014-11-11 | 2015-03-04 | 防城港市万景林业有限公司 | Beverage with roots of kudzu vine and milk |
CN104888128A (en) * | 2015-06-22 | 2015-09-09 | 周崇立 | Traditional Chinese medicine composition for treatment of cancers |
KR102007198B1 (en) * | 2018-02-23 | 2019-08-05 | 금산진생협동조합 | Composition for antiinflammation and antioxidation comprising medicinal herb extract |
KR20200061470A (en) * | 2018-11-23 | 2020-06-03 | 재단법인 진안홍삼연구소 | Method for manufacturing the drink contained black-red ginseng, and the drink manufactured by the method |
KR102393857B1 (en) * | 2020-11-05 | 2022-05-04 | 농업회사법인(주)한국흑삼공사 | Inner Beauty Composition for Skin Improvement comprising Black Ginseng Extract and Collagen |
KR20230101373A (en) * | 2021-12-29 | 2023-07-06 | 대구한의대학교산학협력단 | A beverage composition for preventing or improving hangover |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101380625B1 (en) | 2012-03-13 | 2014-04-10 | 개삼터홍삼직거래 영농조합법인 | Method for producing red ginseng extract comprising medicinal herbs concentrate and plant extract |
KR101413283B1 (en) * | 2012-12-28 | 2014-06-30 | 충청남도 | The method for manufacturing panax ginseng composite by using the complex extract for the enhancement of immunity, and the panax ginseng composite made by the method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100411021B1 (en) * | 2001-11-03 | 2003-12-18 | 주식회사 케이티앤지 | A drink containing the red ginseng, and a method for preparing thereof |
KR20050030992A (en) * | 2003-09-27 | 2005-04-01 | 고한길 | Oriental health food and preparation method thereof |
KR100579010B1 (en) * | 2003-10-21 | 2006-05-12 | 안경섭 | Extracted concentration of gineseng steamed red and herb medicines |
KR101058421B1 (en) * | 2003-11-28 | 2011-08-24 | 고한길 | Herbal dietary supplement and its manufacturing method |
-
2009
- 2009-08-19 KR KR1020090076477A patent/KR101144920B1/en not_active IP Right Cessation
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103494894A (en) * | 2013-10-09 | 2014-01-08 | 南京中医药大学 | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof |
CN104082745A (en) * | 2014-07-10 | 2014-10-08 | 山西大学 | Medicated food for conditioning blood-stasis constitution and improving immune adjustment capability and preparation method of medicated food |
CN104382166A (en) * | 2014-11-11 | 2015-03-04 | 防城港市万景林业有限公司 | Kudzuvine root milk beverage formula |
CN104382168A (en) * | 2014-11-11 | 2015-03-04 | 防城港市万景林业有限公司 | Beverage with roots of kudzu vine and milk |
CN104888128A (en) * | 2015-06-22 | 2015-09-09 | 周崇立 | Traditional Chinese medicine composition for treatment of cancers |
KR102007198B1 (en) * | 2018-02-23 | 2019-08-05 | 금산진생협동조합 | Composition for antiinflammation and antioxidation comprising medicinal herb extract |
KR20200061470A (en) * | 2018-11-23 | 2020-06-03 | 재단법인 진안홍삼연구소 | Method for manufacturing the drink contained black-red ginseng, and the drink manufactured by the method |
KR102393857B1 (en) * | 2020-11-05 | 2022-05-04 | 농업회사법인(주)한국흑삼공사 | Inner Beauty Composition for Skin Improvement comprising Black Ginseng Extract and Collagen |
KR20230101373A (en) * | 2021-12-29 | 2023-07-06 | 대구한의대학교산학협력단 | A beverage composition for preventing or improving hangover |
Also Published As
Publication number | Publication date |
---|---|
KR101144920B1 (en) | 2012-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101144920B1 (en) | An Extract with Red Ginseng and Herbs | |
KR100730647B1 (en) | Aged Concentrate of Ginseng Steamed Red, and a Preparation Method Thereof | |
CN102228180B (en) | Betelnut buccal tablet and preparation method thereof | |
KR20140103622A (en) | The method for manufacturing functional tea product made from onion skin, and the product made by the method | |
KR100854685B1 (en) | Production method of ginseng steamed red concentrated solution and ginseng steamed red concentrated solution produced by this method | |
KR101915031B1 (en) | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts | |
KR101061575B1 (en) | Drinks containing red ginseng and plant extracts | |
KR20130104100A (en) | Method for producing red ginseng extract comprising medicinal herbs concentrate and plant extract | |
KR101394358B1 (en) | Health composition relieving alcohol hangover | |
CN108651652A (en) | Witloof compound surrogated tea | |
KR101162581B1 (en) | Dried Persimmon Having Good Functionality and Method for Preparing the Same | |
CN108497246A (en) | A kind of plant weight losing function beverage and preparation method thereof | |
KR102386574B1 (en) | Health functional drink comprising fermented steam-dreid ginseng berry | |
KR101413283B1 (en) | The method for manufacturing panax ginseng composite by using the complex extract for the enhancement of immunity, and the panax ginseng composite made by the method | |
KR101668447B1 (en) | Composition for curing hanover and health functional foods composition comprising the same | |
KR20220087888A (en) | Black bellflower syrup and method of preparing therefor | |
KR101381277B1 (en) | The wild rice gel containing ginseng | |
CN105285605A (en) | Antitumor ginseng flower health care beverage improving organism immunity | |
CN107509838A (en) | A kind of preparation method of fermented black rice tea | |
CN110881543A (en) | Flower and fruit tea beverage | |
CN109287916A (en) | A kind of preparation method of Sessileflower Acanthopanax Bark extracting solution and its beverage | |
CN101803650A (en) | Compound gingko health protection tea and preparation method thereof | |
CN108477361A (en) | A kind of setose abelmoschus seed Chinese medicine coffee drink and preparation method thereof | |
KR20190116003A (en) | Composition for hangover treatment and manufacturing method for the same | |
CN115530276B (en) | Spleen-strengthening plant drink and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20151104 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20161108 Year of fee payment: 5 |
|
R401 | Registration of restoration | ||
LAPS | Lapse due to unpaid annual fee |